Skip to main content
Premium Trial:

Request an Annual Quote

FDA Renews License to GVK Bio’s Biomarker Database


GVK Biosciences said this week that the US Food and Drug Administration has renewed its license to the Hyderabad, India-based firm's clinical biomarker database.

GVK Bio said that the FDA’s biomarker qualification group renewed its license to the GVK BIO Online Biomarker Database, or GOBIOM, database.

GOBIOM contains clinically evaluated, exploratory, and preclinical biomarkers associated with different therapeutic areas that have been reported in global clinical trials, clinical, and preclinical studies.

Specifically, the resource contains data related to about 20,000 biochemical, genomic, imaging, metabolite, cellular, and physiological biomarkers as well as experimental, analytical, clinical, and statistical information.